Nu-Med Plus annual working capital
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Nu-Med Plus Working Capital Growth & History (NUMD)
Nu-Med Plus's working capital was −$271,278 for fiscal 2025.
View full Nu-Med Plus company overviewNu-Med Plus annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$271,278 | −$56,182 | — |
| 2024 | 2024-12-31 | −$215,096 | −$68,345 | — |
| 2023 | 2023-12-31 | −$146,751 | −$83,726 | — |
| 2022 | 2022-12-31 | −$63,025 | $79,821 | — |
| 2021 | 2021-12-31 | −$142,846 | −$600,321 | — |
| 2020 | 2020-12-31 | $457,475 | $859,728 | — |
| 2019 | 2019-12-31 | −$402,253 | −$413,989 | — |
| 2018 | 2018-12-31 | $11,736 | −$20,564 | −63.67% |
| 2017 | 2017-12-31 | $32,300 | $4.5M | — |
| 2016 | 2016-12-31 | −$4.5M | $10.8M | — |
| 2015 | 2015-12-31 | −$15.3M | −$15.2M | — |
| 2014 | 2014-12-31 | −$94,706 | $94,432 | — |
| 2013 | 2013-12-31 | −$189,138 | −$88,484 | — |
| 2012 | 2012-12-31 | −$100,654 | — | — |
Nu-Med Plus quarterly working capital
As of Dec 31, 2011
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$267,486 | −$20,792 | — |
| Q1 2026 | 2026-03-31 | −$287,156 | −$52,127 | — |
| Q4 2025 | 2025-12-31 | −$271,278 | −$56,182 | — |
| Q3 2025 | 2025-09-30 | −$258,660 | −$54,119 | — |
| Q2 2025 | 2025-06-30 | −$246,694 | — | — |
| Q1 2025 | 2025-03-31 | −$235,029 | −$66,452 | — |
| Q4 2024 | 2024-12-31 | −$215,096 | −$68,345 | — |
| Q3 2024 | 2024-09-30 | −$204,541 | −$72,586 | — |
| Q1 2024 | 2024-03-31 | −$168,577 | −$77,348 | — |
| Q4 2023 | 2023-12-31 | −$146,751 | −$83,726 | — |
| Q3 2023 | 2023-09-30 | −$131,955 | — | — |
| Q2 2023 | 2023-06-30 | −$115,549 | — | — |
| Q1 2023 | 2023-03-31 | −$91,229 | $98,033 | — |
| Q4 2022 | 2022-12-31 | −$63,025 | $79,821 | — |
| Q1 2022 | 2022-03-31 | −$189,262 | −$375,631 | — |
| Q4 2021 | 2021-12-31 | −$142,846 | −$600,321 | — |
| Q3 2021 | 2021-09-30 | −$86,580 | −$292,383 | — |
| Q2 2021 | 2021-06-30 | −$11,212 | −$412,706 | — |
| Q1 2021 | 2021-03-31 | $186,369 | $579,445 | — |
| Q4 2020 | 2020-12-31 | $457,475 | $859,728 | — |
| Q3 2020 | 2020-09-30 | $205,803 | $547,094 | — |
| Q2 2020 | 2020-06-30 | $401,494 | $740,359 | — |
| Q1 2020 | 2020-03-31 | −$393,076 | −$130,353 | — |
| Q4 2019 | 2019-12-31 | −$402,253 | −$413,989 | — |
| Q3 2019 | 2019-09-30 | −$341,291 | −$499,190 | — |
| Q2 2019 | 2019-06-30 | −$338,865 | −$276,174 | — |
| Q1 2019 | 2019-03-31 | −$262,723 | −$207,254 | — |
| Q4 2018 | 2018-12-31 | $11,736 | −$20,564 | −63.67% |
| Q3 2018 | 2018-09-30 | $157,899 | $150,461 | +2022.87% |
| Q2 2018 | 2018-06-30 | −$62,691 | $73,533 | — |
| Q1 2018 | 2018-03-31 | −$55,469 | $2,476 | — |
| Q4 2017 | 2017-12-31 | $32,300 | $4.5M | — |
| Q3 2017 | 2017-09-30 | $7,438 | $168,916 | — |
| Q2 2017 | 2017-06-30 | −$136,224 | −$687,266 | — |
| Q1 2017 | 2017-03-31 | −$57,945 | $224,284 | — |
| Q4 2016 | 2016-12-31 | −$4.5M | $10.8M | — |
| Q3 2016 | 2016-09-30 | −$161,478 | $86,477 | — |
| Q2 2016 | 2016-06-30 | $551,042 | $769,775 | — |
| Q1 2016 | 2016-03-31 | −$282,229 | −$70,687 | — |
| Q4 2015 | 2015-12-31 | −$15.3M | −$15.2M | — |
| Q3 2015 | 2015-09-30 | −$247,955 | −$153,249 | — |
| Q2 2015 | 2015-06-30 | −$218,733 | −$450,822 | — |
| Q1 2015 | 2015-03-31 | −$211,542 | −$277,034 | — |
| Q4 2014 | 2014-12-31 | −$94,706 | $94,432 | — |
| Q3 2014 | 2014-09-30 | −$94,706 | $92,536 | — |
| Q2 2014 | 2014-06-30 | $232,089 | $441,785 | — |
| Q1 2014 | 2014-03-31 | $65,492 | $243,919 | — |
| Q4 2013 | 2013-12-31 | −$189,138 | −$88,484 | — |
| Q3 2013 | 2013-09-30 | −$187,242 | — | — |
| Q2 2013 | 2013-06-30 | −$209,696 | — | — |
| Q1 2013 | 2013-03-31 | −$178,427 | — | — |
| Q4 2012 | 2012-12-31 | −$100,654 | −$99,824 | — |
| As of Dec 31, 2011 | 2011-12-31 | −$830 | — | — |
Nu-Med Plus working capital trends
Over the last five fiscal years, Nu-Med Plus's working capital decreased from $457,475 to −$271,278, a change of −$728,753. The latest reported quarter, Q2 2026, shows −$267,486.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nu-Med Plus source filings ↗